Here we have shown that the adaptor molecule, CRKL, is a direct miR-200bc target, functionally affecting experimental migration, invasion and metastasis of lung cancer cells and clinically prognostic of outcome in multiple tumor types from analysis of TCGA datasets. Here, CRKL is linked to neoplasm.